DOCSLIB.ORG

Understanding Atopic Dermatitis Know Your Skin – from the Inside Out

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Understanding Atopic Dermatitis Know Your Skin – from the Inside Out Understanding Atopic Dermatitis Know Your Skin – From the Inside Out Special Edition of ATOPIC DERMATITIS DEFINED Who We Are Allergy & Asthma Network is the leading nonprofit patient outreach, education, advocacy and research organization for people with asthma, allergies and related conditions. 8229 Boone Blvd. Suite 260 Our patient-centered network Vienna, VA 22182 unites individuals, families, 800.878.4403 healthcare professionals, industry AllergyAsthmaNetwork.org leaders and government decision- [email protected] makers to improve health and quality of life for the millions of Understanding Atopic Dermatitis people affected by asthma and – Allergy & Asthma Today Special allergies. Edition is published by Allergy & Asthma Network, Copyright An innovator in encouraging 2018. All rights reserved. family participation in treatment plans, Allergy & Asthma Network Call 800.878.4403 to order specializes in making accurate copies; shipping and handling medical information relevant charges apply. and understandable to all while promoting standards of care that are proven to work. We believe PUBLISHER that integrating prevention with Allergy & Asthma Network treatment helps reduce emergency healthcare visits, keep children in PRESIDENT AND CEO school and adults at work, and Tonya Winders allow participation in sports and other activities of daily life. MANAGING EDITOR Gary Fitzgerald Our Mission CREATIVE DIRECTOR To end needless death and suffering Paul Tury due to asthma, allergies and related conditions through outreach, DIRECTOR OF EDUCATION education, advocacy and research. Sally Schoessler CONTRIBUTORS Allergy & Asthma Network is a Allie Bahn 501(c)(3) organization. Tracy Bush Kortney Kwong Hing Join Allergy & Asthma Network Abby Lai today, as we work to help Kimberly Pellicore patients and families Laurie Ross breathe better together. AllergyAsthmaNetwork.org/join Comments and Questions [email protected] Editorial reviewed by: Luz Fonacier, MD Purvi Parikh, MD Weily Soong, MD Dennis Williams, PharmD 2 Allergy & Asthma Today Special Edition AllergyAsthmaNetwork.org INSIDE: Beyond Skin Deep ATOPIC DERMATITIS DEFINED Dry, cracked, inflamed skin. A red, bumpy rash that won’t go away. The near-constant itching and sleepless nights. Living with atopic 4 What is Atopic Dermatitis? dermatitis (AD) – the most common form of eczema – isn’t easy. It’s 7 Atopic Dermatitis Fast Facts often unpredictable, with skin symptoms arising when you least 8 The Allergic March expect it. 9 Type 2 Inflammation Maybe you’re in your mid-20s and eager to go on dates, but also apprehensive because red splotches are visible on your cheek, chin and SYMPTOMS neck. Perhaps you’re the parent of a 10-month-old girl who scratched the rough, scaly skin on her arms so hard it started bleeding. Or maybe 10 What to Watch For... you’re a 40-something with seasonal allergies, 11 A Clear Diagnosis perplexed by the onset of skin inflammation on 12 What’s Worsening My Eczema? your hands and feet. 14 When to See a Specialist Atopic dermatitis is a lifelong condition – there is no cure. The goal of care is to provide TREATMENTS & MEDICATIONS relief. More than 18 million adults and 9.6 million children have it. Doctors believe AD 15 Repair the Skin Barrier may actually be underdiagnosed – many people 16 To Bathe Or Not to Bathe? are unaware they have it or don’t seek out 17 Under Wraps medical care, thinking symptoms will go away 18 Come Together: How Doctor-Patient on their own. Partnerships Are Transforming Further, atopic dermatitis can impact Healthcare patients’ mental health and quality of life. Even those with mild 19 What’s the Best Treatment For My Atopic Dermatitis? symptoms report it limits their lifestyle and participation in social 20 Find Your Relief activities. 23 Let There Be Light Where to start in terms of managing the condition? First things first: see a doctor – specialists who treat atopic dermatitis include board-certified allergists and dermatologists. You’ll undergo MANAGING YOUR CONDITION tests to confirm the condition and find out what your triggers are. Since AD is believed to be genetic, your family history will be part of the 24 Calming the Itch discussion. 25 Sleep Tight Then you’ll work together with your doctor to develop a practical 26 The Heat Is On management and treatment plan specific to your needs and values. 26 Baby It’s Cold Outside The key, as you’ll learn in this guidebook, is to keep your skin 27 Don’t Keep It a Secret 28 Stress-Busters moisturized, regardless of the severity of the condition. If your atopic 29 Recipe for Success dermatitis persists, there is hope. New, innovative medications give 30 Coping With Eczema doctors and patients better tools to keep symptoms in check. 31 Dating and Intimacy You don’t have to struggle – physically or emotionally – with atopic 32 When Eczema Goes to School dermatitis. Clear, healthy skin is possible. Help is here. 33 Come Clean ADDITIONAL RESOURCES Tonya Winders 34 Dictionary, Websites and President/CEO Publications Allergy & Asthma Network 800.878.4403 Understanding Atopic Dermatitis 3 ATOPIC DERMATITIS DEFINED “Every time work “My 3-year- is stressful, I break old son has out in red, scaly had problem splotches. It’s really skin since he itchy and painful was born. We on my hand and bathe him every arms – it’s hard not other night with to scratch – but it’s water only, then most embarrassing moisturize and when it shows up let it soak in on my cheek and before he puts chin.” on his pajamas. – Destiny, 26 Moisturizing is really the key for us!” – Marcie, 39 What is Atopic Dermatitis? f you’ve had it, you know it: the dry, red, scaly, AD symptoms will come and go, but even when unbearably itchy skin condition called atopic your skin appears clear, there may be inflammation Idermatitis, or AD – the most common form of eczema. underneath the surface, waiting to flare. You are not alone: 18 million adults (7.2 percent) and Atopic dermatitis often develops in early childhood 9.6 million children under the age of 18 (13 percent) – appearing during the first 6 months or within the first have AD, according to the National Eczema Association. 5 years. Among children, 3.2 million have moderate-to-severe symptoms. Under the Skin Atopic dermatitis is a chronic inflammatory skin While its cause is unknown, doctors believe AD is disease. It can cause red patches on the skin that itch; related to genetics, an immune system that is sensitive dry and scaly skin; thickened skin; and open, oozing, to allergens and irritants, and a defective skin barrier crusty sores. AD symptoms often appear on the face, that allows moisture to escape and allergens and bacteria neck, hands, wrists, elbows, knees, ankles and feet. to invade. Seventy percent of people with AD report a 4 Allergy & Asthma Today Special Edition AllergyAsthmaNetwork.org ATOPIC DERMATITIS DEFINED “My skin breaks “My daughter out with red, had severe atopic itchy bumps dermatitis from when my dog birth until she jumps on me. It was about 6 hurts pretty bad months old. Within when I scratch 24 hours after it. One time it switching her diet got infected. I to a hypoallergenic try to avoid our formula, her skin dog now, but it’s was silky smooth hard.” and has been for – Dev, 16 almost two years. I encourage parents to explore food allergies if their child has atopic dermatitis.” – Whitney, 32 family history of the condition. Some people with atopic The most common TRUE OR FALSE? dermatitis may lack a specific environmental allergens that Atopic dermatitis is contagious. type of protein, called filaggrin, trigger symptoms include dust in their skin. This protein serves as FALSE! mites, pet dander, pollen and mold. a protective barrier from allergens, You cannot “catch it” or spread Food allergens are also possible irritants and infections. When it to others through physical triggers, especially in children. Irritants filaggrin is lacking, it weakens the skin contact. Atopic dermatitis such as wool or man-made fibers, barrier function of the skin. Some people does tend to run detergents, soaps, cleaning products, some with atopic dermatitis also have high blood in families, but skin care products and tobacco smoke are also levels of Immunoglobulin E (IgE), antibodies this is due to common triggers. produced by the immune system that set off genetics. Exposure to these allergens and irritants allergy symptoms. triggers immune cells to release histamines, cytokines and other chemicals to rid the irritants On the Skin from the body. The resulting inflammation signals the Early diagnosis and treatment are essential to avoid brain to move your hand to the itchy spot and scratch skin complications and improve quality of life. … and scratch. That only makes it worse, resulting in an Treatment begins with avoiding or reducing exposures endless cycle. to known allergens and irritants – immunotherapy Too much scratching can lead to infection if the to build tolerance to allergens is one option. Then, surface of the skin is broken. Signs of infection include keep your skin moisturized with creams or ointments, yellowish, crusty skin (often on top of the eczema), red, especially during hot summers and dry winters, to lock swollen bumps and pus-filled blisters. moisture in your skin and protect against future rashes. 800.878.4403 Understanding Atopic Dermatitis 5 ATOPIC DERMATITIS DEFINED “I play basketball in a men’s league The Eczema Umbrella every winter, and Eczema is often used interchangeably with about an hour after atopic dermatitis. The word has Greek origins – it the game is over, means “to boil over.” It applies broadly to a range of persistent skin conditions: my neck, arms and knee turn red, • Atopic dermatitis: a chronic and recurrent inflammatory skin condition that causes red, scaly and itchy.
Load more

Recommended publications
  • Autoimmune Associations of Alopecia Areata in Pediatric Population - a Study in Tertiary Care Centre
    IP Indian Journal of Clinical and Experimental Dermatology 2020;6(1):41–44 Content available at: iponlinejournal.com IP Indian Journal of Clinical and Experimental Dermatology Journal homepage: www.innovativepublication.com Original Research Article Autoimmune associations of alopecia areata in pediatric population - A study in tertiary care centre Sagar Nawani1, Teki Satyasri1,*, G. Narasimharao Netha1, G Rammohan1, Bhumesh Kumar1 1Dept. of Dermatology, Venereology & Leprosy, Gandhi Medical College, Secunderabad, Telangana, India ARTICLEINFO ABSTRACT Article history: Alopecia areata (AA) is second most common disease leading to non scarring alopecia . It occurs in Received 21-01-2020 many patterns and can occur on any hair bearing site of the body. Many factors like family history, Accepted 24-02-2020 autoimmune conditions and environment play a major role in its etio-pathogenesis. Histopathology shows Available online 29-04-2020 bulbar lymphocytes surrounding either terminal hair or vellus hair resembling ”swarm of bees” appearance depending on chronicity of alopecia areata. Alopecia areata in children is frequently seen. Pediatric AA has been associated with atopy, thyroid abnormalities and a positive family history. We have done a study to Keywords: find out if there is any association between alopecia areata and other auto immune diseases in children. This Alopecia areata study is an observational study conducted in 100 children with AA to determine any associated autoimmune Auto immunity conditions in them. SALT score helps to assess severity of alopecia areata. Severity of alopecia areata was Pediatric population assessed by SALT score-1. S1- less than 25% of hairloss, 2. S2- 25-49% of hairloss, 3. 3.S3- 50-74% of hairloss.
    [Show full text]
  • The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis Rana Herro1, Ricardo Da S
    ORIGINAL ARTICLE The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis Rana Herro1, Ricardo Da S. Antunes1, Amelia R. Aguilera1, Koji Tamada2 and Michael Croft1 Several inflammatory diseases including scleroderma and atopic dermatitis display dermal thickening, epidermal hypertrophy, or excessive accumulation of collagen. Factors that might promote these features are of interest for clinical therapy. We previously reported that LIGHT, a TNF superfamily molecule, mediated collagen deposition in the lungs in response to allergen. We therefore tested whether LIGHT might similarly promote collagen accumulation and features of skin fibrosis. Strikingly, injection of recombinant soluble LIGHT into naive mice, either subcutaneously or systemically, promoted collagen deposition in the skin and dermal and epidermal thickening. This replicated the activity of bleomycin, an antibiotic that has been previously used in models of scleroderma in mice. Moreover skin fibrosis induced by bleomycin was dependent on endogenous LIGHT activity. The action of LIGHT in vivo was mediated via both of its receptors, HVEM and LTβR, and was dependent on the innate cytokine TSLP and TGF-β. Furthermore, we found that HVEM and LTβR were expressed on human epidermal keratinocytes and that LIGHT could directly promote TSLP expression in these cells. We reveal an unappreciated activity of LIGHT on keratinocytes and suggest that LIGHT may be an important mediator of skin inflammation and fibrosis in diseases such as scleroderma
    [Show full text]
  • Skin Manifestation of SARS-Cov-2: the Italian Experience
    Journal of Clinical Medicine Article Skin Manifestation of SARS-CoV-2: The Italian Experience Gerardo Cazzato 1 , Caterina Foti 2, Anna Colagrande 1, Antonietta Cimmino 1, Sara Scarcella 1, Gerolamo Cicco 1, Sara Sablone 3, Francesca Arezzo 4, Paolo Romita 2, Teresa Lettini 1 , Leonardo Resta 1 and Giuseppe Ingravallo 1,* 1 Section of Pathology, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] (G.C.); [email protected] (A.C.); [email protected] (A.C.); [email protected] (S.S.); [email protected] (G.C.); [email protected] (T.L.); [email protected] (L.R.) 2 Section of Dermatology and Venereology, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] (C.F.); [email protected] (P.R.) 3 Section of Forensic Medicine, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] 4 Section of Gynecologic and Obstetrics Clinic, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] * Correspondence: [email protected] Abstract: At the end of December 2019, a new coronavirus denominated Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified in Wuhan, Hubei province, China. Less than three months later, the World Health Organization (WHO) declared coronavirus disease-19 (COVID-19) to be a global pandemic. Growing numbers of clinical, histopathological, and molecular findings were subsequently reported, among which a particular interest in skin manifestations during the course of the disease was evinced. Today, about one year after the development of the first major infectious foci in Italy, various large case series of patients with COVID-19-related skin Citation: Cazzato, G.; Foti, C.; manifestations have focused on skin specimens.
    [Show full text]
  • Shingles (Herpes Zoster) Hives (Urticaria) Psoriasis
    Shingles (Herpes Zoster) Shingles starts with burning, tingling, or very sensitive skin. A rash of raised dots develops into painful blisters that last about two weeks. Shingles often occurs on the trunk and buttocks, but can appear anywhere. Most people recover, but pain, numbness, and itching linger for many -- and may last for months, years, or the rest of their lives. Treatment with antiviral drugs, steroids, antidepressants, and topical agents can help. Hives (Urticaria) A common allergic reaction that looks like welts, hives are often itchy, and sometimes stinging or burning. Hives vary in size and may join together to form larger areas. They may appear anywhere and last minutes or days. Medications, foods, food additives, temperature extremes, and infections like strep throat are some causes of hives. Antihistamines can provide relief. Psoriasis A non-contagious rash of thick red plaques covered with white or silvery scales, psoriasis usually affects the scalp, elbows, knees, and lower back. The rash can heal and recur throughout life. The cause of psoriasis is unknown, but the immune system triggers new skin cells to develop too quickly. Treatments include medications applied to the skin, light therapy, and medications taken by mouth, injection or infusion. Eczema Eczema describes several non-contagious conditions where skin is inflamed, red, dry, and itchy. Stress, irritants (like soaps), allergens, and climate can trigger flare-ups though they're not eczema's exact cause, which is unknown. In adults, eczema often occurs on the elbows and hands, and in "bending" areas, such as inside the elbows. Treatments include topical or oral medications and shots.
    [Show full text]
  • BETA Betamethasone Valerate Cream 0.1% W/W Betamethasone Valerate Ointment 0.1% W/W
    NEW ZEALAND CONSUMER MEDICINE INFORMATION BETA Betamethasone valerate cream 0.1% w/w Betamethasone valerate ointment 0.1% w/w discoid lupus Some of the symptoms of an What is in this leaflet erythematosus (recurring allergic reaction may include: scaly rash) shortness of breath; wheezing or This leaflet answers some common prickly heat skin reaction difficulty breathing; swelling of the questions about BETA Cream and insect bite reactions face, lips, tongue or other parts of Ointment. prurigo nodularis (an itching the body; rash, itching or hives on and thickening of the skin the skin. It does not contain all the available with lumps or nodules) information. It does not take the contact sensitivity reactions Do not use BETA Cream or place of talking to your doctor or an additional treatment for Ointment to treat any of the pharmacist. an intense widespread following skin problems as it reddening and inflammation could make them worse: All medicines have risks and of the skin, infected skin (unless the benefits. Your doctor has weighed when milder topical corticosteroids infection is being treated the risks of you using BETA Cream cannot treat the skin condition with an anti-infective or Ointment against the benefits effectively. medicine at the same time) they expect it will have for you. acne BETA Cream is usually used to rosacea (a facial skin If you have any concerns about treat skin conditions on moist condition where the nose, taking this medicine, ask your surfaces; BETA Ointment is usually cheeks, chin, forehead or doctor or pharmacist. used to treat skin conditions on dry, entire face are unusually scaly skin.
    [Show full text]
  • Erythema Annulare Centrifugum ▪ Erythema Gyratum Repens ▪ Exfoliative Erythroderma Urticaria ▪ COMMON: 15% All Americans
    Cutaneous Signs of Internal Malignancy Ted Rosen, MD Professor of Dermatology Baylor College of Medicine Disclosure/Conflict of Interest ▪ No relevant disclosures ▪ No conflicts of interest Objectives ▪ Recognize common disorders associated with internal malignancy ▪ Manage cutaneous disorders in the context of associated internal malignancy ▪ Differentiate cutaneous signs of leukemia and lymphoma ▪ Understand spidemiology of cutaneous metastases Cutaneous Signs of Internal Malignancy ▪ General physical examination ▪ Pallor (anemia) ▪ Jaundice (hepatic or cholestatic disease) ▪ Fixed erythema or flushing (carcinoid) ▪ Alopecia (diffuse metastatic disease) ▪ Itching (excoriations) Anemia: Conjunctival pallor and Pale skin Jaundice 1-12% of hepatocellular, biliary tree or pancreatic cancer PRESENT with jaundice, but up to 40-60% eventually develop it World J Gastroenterol 2003;9:385-91 For comparison CAN YOU TELL JAUNDICE FROM NORMAL SKIN? JAUNDICE Alopecia Neoplastica Most common report w/ breast CA Lung, cervix, desmoplastic mm Hair loss w/ underlying induration Biopsy = dermis effaced by tumor Ann Dermatol 26:624, 2014 South Med J 102:385, 2009 Int J Dermatol 46:188, 2007 Acta Derm Venereol 87:93, 2007 J Eur Acad Derm Venereol 18:708, 2004 Gastric Adenocarcinoma: Alopecia Ann Dermatol 2014; 26: 624–627 Pruritus: Excoriation ▪ Overall risk internal malignancy presenting as itch LOW. OR =1.14 ▪ CTCL, Hodgkin’s & NHL, Polycythemia vera ▪ Biliary tree carcinoma Eur J Pain 20:19-23, 2016 Br J Dermatol 171:839-46, 2014 J Am Acad Dermatol 70:651-8, 2014 Non-specific (Paraneoplastic) Specific (Metastatic Disease) Paraneoplastic Signs “Curth’s Postulates” ▪ Concurrent onset (temporal proximity) ▪ Parallel course ▪ Uniform site or type of neoplasm ▪ Statistical association ▪ Genetic linkage (syndromal) Curth HO.
    [Show full text]
  • Effectiveness of Medium-Dose Ultraviolet A1 Phototherapy in Localized Scleroderma
    Pharmacology and therapeutics Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma Ozlem Su1, MD, Nahide Onsun1, MD, Hulya Kapran Onay2, MD, Yeliz Erdemoglu1, MD, Dilek Biyik Ozkaya1, MD, Filiz Cebeci1, MD, and Adnan Somay3, MD 1Department of Dermatology, Abstract Bezmialem Vakif University, Faculty of Background Recently, ultraviolet (UV) A1 phototherapy has been suggested as an effec- 2 Medicine, Neoson Imaging Center, tive treatment for localized scleroderma (LS); however, the optimal dose of UVA1 still has Radiology, and 3Department of not been determined. Pathology, Vakif Gureba Teaching and 2 Research Hospital, Istanbul, Turkey Objective We aimed to evaluate the therapeutic effectiveness of medium-dose (30 J/cm ) UVA1 phototherapy and to show that 13 MHz ultrasound is a valuable tool for assessing Correspondence the results of UVA1 phototherapy in LS. Ozlem Su, MD Methods Thirty-five patients with LS were treated with medium-dose (30 J/cm2) UVA1. Sıgırtmac Sok. No. 21 B blok d. 7 In total, 30–45 treatments and 900–1350 J/cm2 cumulative UVA1 doses were evaluated by Osmaniye Bakirkoy clinical scoring in all patients. In 14 patients, skin thickness was also determined by Istanbul 13 MHz ultrasound examination. Turkey Results In all patients, medium-dose UVA1 therapy softened sclerotic plaques, and E-mail: [email protected] marked clinical improvement was observed in 29 of 35 (82. 85%) patients. Ultrasound mea- surements showed that skin thickness was significantly reduced. No side effects were Conflicts of interest: None. observed during or after treatment. Conclusion Medium-dose UVA1 phototherapy is a highly effective, safe, and well-tolerated therapeutic modality for treatment of all types of LS.
    [Show full text]
  • Drug Eruptions.Pdf
    Drug eruptions & reactions What are drug eruptions? Drug reactions are unwanted and unexpected reactions occurring in the skin (and sometimes other organ systems) that may result from taking a medication for the prevention, diagnosis or treatment of a medical problem. They may appear after the correct use of the medication or drug. It may also appear due to overdose (wrong dose is taken), following accumulation of drugs in the body over time, or by interactions with other medications being taken or used by the person. Drug eruptions could be caused by an allergy or hypersensitivity to the drug, by a direct toxic effect of the drug or medication on the skin, or by other mechanisms. Drug eruptions vary in severity – from a minor nuisance to a more severe problem – and may even cause death. Drug eruptions occur in up to 15% of courses of drug prescribed by medical or natural therapy practitioners. What causes drug eruptions? Drug eruptions are caused by medications which are prescribed by your doctor, purchased over-the- counter or purchased as compounded herbal/naturopathic medicines. Drugs taken orally, injected, delivered by patch application, rubbed onto the skin (e.g. creams, ointments and lotions) can all cause reactions. The potential to develop an adverse reaction to a drug is influenced by the age, gender and genetic makeup of the person; the nature of the condition being treated; and the possible interactions with other medications being taken. Some classes of drugs are known to cause drug eruptions more commonly than others. What do drug eruptions look like in the skin? The appearance of drug eruptions varies depending on the mechanism of the drug reaction.
    [Show full text]
  • Decreased Adhesion Molecules Expression on Granuloma Forming
    THE EGYPTIAN JOURNAL OF IMMUNOLOGY Vol. 22 (1), 2015 Page: 29-40 Level of IL-16 and Reticulated Platelets Percentage during the Clinical Course of Immune Thrombocytopenic Purpura in Children 1Reem R. Abd El-Glil, 2Effat H. Assar Departments of 1Microbiology & Immunology and 2Pediatric, Faculty of Medicine, Benha University, Benha, Egypt. Immune thrombocytopenic purpura (ITP) is an immune-mediated acquired disease with transient or persistent decrease of thrombocytes number in the blood. Cytokines play important roles in the immune regulation and are known to be deregulated in autoimmune diseases. This study aimed to investigate serum IL-16 levels in relation to reticulated platelets in children with ITP and platelet count. Twenty six children with ITP (11 with newly diagnosed ITP, 9 with persistent ITP and 6 with chronic ITP) and 12 age-matched healthy children controls were studied. Serum level of IL-16 and reticulated platelets count were assessed by Enzyme Linked Immunosorbent Assay (ELISA) and flow cytometry respectively. Serum IL-16 levels were significantly higher in patients as compared to controls (P<0.001).Within patients, the levels were higher in newly diagnosed compared to persistent and chronic ITP (P<0.01) and (P<0.001) respectively. IL-16 levels were also significantly higher in persistent ITP compared to chronic ITP (P<0.001). Reticulated platelets were also elevated in patients compared to controls and the increase was significant in newly diagnosed group (P<0.05). Negative correlation was found between IL-16 level and reticulated platelets and platelets counts (r=-0.284, P=0.028, r=0.274 P=0.25) respectively.
    [Show full text]
  • Dupilumab Is a Predominant Treatment for Recalcitrant Bullous Pemphigoid
    Somato Publications ISSN: 2688-1071 Archives of Clinical Case Reports Case Report Dupilumab is a Predominant Treatment for Recalcitrant Bullous Pemphigoid Nozomi Yonei* Division of Dermatology, Naga Municipal Hospital, 1282 Uchita, Kinokawa, Wakayama 649-6414, Japan *Address for Correspondence: Nozomi Yonei, Division of Dermatology, Naga Municipal Hospital, 1282 Uchita, Kinokawa, Wakayama 649-6414, Japan, Tel: +81-736-77-2019; E-mail: [email protected] Received: 01 February 2021; Accepted: 22 February 2021; Published: 24 February 2021 Citation of this article: Nozomi Yonei. (2020) Dupilumab is a Predominant Treatment for Recalcitrant Bullous Pemphigoid. Arch Clin Case Rep, 4(1): 01-04. Copyright: © 2021 Nozomi Yonei. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Bullous pemphigoid is occasionally recalcitrant to established medications. Our 72-year-old male patient was treated with established medications such as systemic corticosteroid (prednisone 1.3_0.7mg/kg), methylprednisolone pulse therapy, 7 up, and many complications such as aspiratory pneumonia, chronic urinary infection, hypoalbuminemia were observed. doses of monthly intravenous immunoglobulin, cyclosporine. During tapering of prednisone, the disease activity easily flared Given the patient’s severe disease status and treatment limitations, we introduced dupilumab expecting Th2-suppressive effect, according to the dosing regimen approved for atopic dermatitis. After 2 months of dupilumab therapy, BPDAI (Bullous Pemphigoid Disease Area Index) score halved, and after 3 months, he accomplished the clearance of the lesions. A place- bo-controlled phase 3 clinical trial of dupilumab for severe BP is now under way, and it is expected that the effectiveness of dupilumab for BP will be proved in the near future.
    [Show full text]
  • Understanding Eczema / Atopic Dermatitis
    Understanding Atopic Dermatitis An educational health series from National Jewish Health If you would like further information about National Jewish Health, please write to: National Jewish Health 1400 Jackson Street Denver, Colorado 80206 or visit: njhealth.org Understanding Atopic Dermatitis An educational health series from National Jewish Health IN THIS ISSUE About Atopic Dermatitis 2 What Causes Atopic Dermatitis? 3 Do You Have Atopic Dermatitis? 3 Should You Go to an Expert? 4 What Are Your Goals? 4 Avoiding Things that Make Itching and Rash Worse 5 Treatment and Medication Therapy 9 Soak and Seal 9 What Medicines Will Help? 10 Action Plan for Atopic Dermatitis 13 What to Do When Symptoms Are Severe 14 Living with Atopic Dermatitis 15 Remember Your Goals 15 Glossary 16 Note: This information is provided to you as an educational service of National Jewish Health. It is not meant as a substitute for your own doctor. © Copyright 2018, National Jewish Health About Atopic Dermatitis Atopic dermatitis is a common chronic skin disease. It is also called atopic eczema. Atopic is a term used to describe allergic conditions such as asthma and hay fever. Both dermatitis and eczema mean inflammation of the skin. People with atopic dermatitis tend to have dry, itchy and easily irritated skin. They may have times when their skin is clear and other times when they have rash. INFANTS AND SMALL CHILDREN In infants and small children, the rash is often present on face, as well as skin around the knees and elbows. TEENAGERS AND ADULTS In teenagers and adults, the rash is often present in the creases of the wrists, elbows, knees or ankles, and on the face or neck.
    [Show full text]
  • Itching to Know More About Eczema and Ectodermal Dysplasia
    ITCHING TO KNOW MORE ABOUT ECZEMA AND ECTODERMAL DYSPLASIA Eczema, sometimes called dermatitis, is inflammation of the skin that can lead to an itchy rash. There are many different types of eczema, but the most common kind of eczema is atopic dermatitis. When people refer to eczema, they are typically referring to atopic dermatitis. This condition affects up to 20% of people worldwide, particularly infants and children. Individuals with ectodermal dysplasia, especially hypohidrotic ectodermal dysplasia (HED), are affected even more commonly than the general population with up to 50% having atopic dermatitis. The exact cause of atopic seasonal allergies, asthma or and on the neck and face. dermatitis is unknown. But, eczema. As the rash becomes more there are many factors that established, the dry skin may make a person prone to this Rarely, atopic dermatitis may be become thickened, leathery, and type of rash. We know the related to food sensitivity, but sometimes darker in coloration main issue in eczema is that this is actually quite rare as food due to repetitive rubbing and the skin barrier that holds in allergies typically cause hives scratching. moisture and protects us is not and not eczema. In the majority functioning optimally. This is of cases, no allergic triggers When the rash improves, the case even in those without can be found. Therefore, allergy the skin may appear lighter ectodermal dysplasia, but the testing in most cases is not for some time, especially in poorly developed sweat and necessary or helpful in treating a the summer months but this oil glands likely affect the skin person’s eczema.
    [Show full text]